Theralase(R) Announces $4 Million Brokered LIFE Offering
Toronto, Ontario--(Newsfile Corp. - May 5, 2026) - Theralase® Technologies Inc. (TSXV: TLT) (OTCQB: TLTFF) ("Theralase®" or the "Company"), a clinical stage pharmaceutical company dedicated to the research and development of energy-activated small molecules for the safe and effective destruction of cancer, bacteria and v
Technologies, Biotechnologies, Soins de santé et hôpitaux, Pharmaceutique
2026-05-05 7:10 PM EDT | Theralase Technologies Inc.
Illumisoft Lighting Corp. Provides Corporate Update Following Commencement of Trading
Vancouver, British Columbia--(Newsfile Corp. - May 5, 2026) - Illumisoft Lighting Corp. (TSXV: UVC) (the "Company" or "Illumisoft"), a Canadian public company commercializing UV-based air disinfection technologies and a leading portfolio of energy efficient commercial LED lighting products, today provided the following corporate update. TSX-V Listing and Public Company Platform On April 23, 2026, Illumisoft Lighting Corp. commenced trading on the TSX Venture Exchange
Technologies, Biotechnologies, Soins de santé et hôpitaux, Produits ménagers / de consommation / cosmétiques
2026-05-05 9:16 AM EDT | Illumisoft Lighting Corporation
Breathe BioMedical Expands Multi-Center Clinical Study in Breast Cancer to Pittsburgh
New Brunswick and Cambridge, Massachusetts--(Newsfile Corp. - May 5, 2026) - Breathe BioMedical, a company developing a breath analytics platform for early disease detection, today announced the addition of Weinstein Imaging Associates in Pittsburgh, Pennsylvania as a new clinical site in its large multi-center observational collection protocol study to advanc
Technologies, Biotechnologies, Soins de santé et hôpitaux, Santé
2026-05-05 9:00 AM EDT | Breathe BioMedical Inc.
Therma Bright Announces Follow-On Order from Horizon Health as Venowave(TM) Gains Traction in U.S. Vascular Markets
Toronto, Ontario--(Newsfile Corp. - May 5, 2026) - Therma Bright Inc. (TSXV: THRM) (OTCQB: TBRIF) (FSE: JNX0) ("Therma" or the "Company"), a developer and investment partner specializing in advanced medical device technologies, is pleased to announce that Horizon Health ("Horizon") has purchased an additional 100 Venowave™ units. This second commercial order follows the rapid deployment and clinical success of the initial 100-unit shipment delivered to Horizon in la
Technologies, Biotechnologies, Santé
2026-05-05 6:30 AM EDT | Therma Bright Inc.
Restart Life Sciences Reports Holy Crap Foods Revenue Gains of 46% in Wholesale and 32% via Amazon Channels YoY
Vancouver, British Columbia--(Newsfile Corp. - May 5, 2026) - Restart Life Sciences Corp. (CSE: HEAL) (FSE: HN30) (OTC Pink: NMLSF) ("Restart Life" or the "Company") is pleased to report a significant revenue milestone for April 2026, marking a period of substantial growth following the integration of Holy Crap Foods Inc. Since completing the acquisition on February 27, 2026, the Company has executed a strategic roadmap focused on stabilizing operations, optimizing channel efficiency, a
Technologies, Biotechnologies, Santé
2026-05-05 6:00 AM EDT | Restart Life Sciences Corp.
Bachem Announces Changes to the Corporate Executive Committee
Bubendorf, Switzerland--(Newsfile Corp. - May 5, 2026) - Bachem Holding AG (SIX: BANB) (“Bachem”) today announced that Torsten Wöhr, Chief Commercial Officer, has decided to pursue a new opportunity outside the company. Until a successor will be appointed, Anne-Kathrin Stoller will assume the role of Chief Commercial Officer in addition to her responsibilities as Chief Executive Officer (CEO), effective May 25, 2026. “Torsten Wöhr
Biotechnologies, Produits chimiques, Soins de santé et hôpitaux, Pharmaceutique
2026-05-05 1:08 AM EDT | Bachem Holding AG
Scryb Inc. Changes Name to NorthPalm Capital Corp. and Announces New Trading Symbols
Toronto, Ontario--(Newsfile Corp. - May 4, 2026) - NorthPalm Capital Corp. (CSE: NP) ("NorthPalm Capital" or the "Company") (formerly, Scryb Inc.), is pleased to announce that further to its news release dated April 15, 2026, the Company's common shares will commence trading on the Canadian Securities Exchange under the new name, "NorthPalm Capital Corp." effective at the market open on May 7, 2026 (the "Name Change") and the trading symbol for the Company will cha
Biotechnologies, Soins de santé et hôpitaux, Santé
2026-05-04 9:41 PM EDT | NorthPalm Capital Corp.
Theralase(R) Releases 2025 Annual Financial Statements and Provides Clinical Study Update
Toronto, Ontario--(Newsfile Corp. - May 4, 2026) - Theralase® Technologies Inc. (TSXV: TLT) (OTCQB: TLTFF) ("Theralase®" or the "Company"), a clinical stage pharmaceutical company dedicated to the research and development of energy-activated small molecules for the safe and effective destruction of various cancer, bacteria and viruses has released the Company's audited consolidated financial statements for the twelve-month period ended December 31
Technologies, Biotechnologies, Soins de santé et hôpitaux, Pharmaceutique
2026-05-04 5:22 PM EDT | Theralase Technologies Inc.
Neural Therapeutics Announces Filing and Mailing of Meeting Materials for Annual and Special Meeting to Approve Series B Transactions with CWE
Toronto, Ontario--(Newsfile Corp. - May 1, 2026) - Neural Therapeutics Inc. (CSE: NURL) (FSE: HANF) ("Neural" or the "Company"), an ethnobotanical drug discovery company focused on developing therapeutic solutions for mental health conditions related to substance use disorders, announces that it has filed on SEDAR+ and completed the mailing of its notice of annual and special meeting, management information circular and related meeting materials (collectively, the "Mee
Biotechnologies, Pharmaceutique, Santé, Psychédéliques
2026-05-01 8:04 AM EDT | Neural Therapeutics Inc.
Three Finalists Announced for the 2026 Bloom Burton Award
Toronto, Ontario--(Newsfile Corp. - May 1, 2026) - Bloom Burton & Co. ("Bloom Burton") is thrilled to announce the finalists for the 2026 Bloom Burton Award. Bestowed annually and nominated by the public at large, the Bloom Burton Award honours an individual who made the greatest contribution to Canada's innovative healthcare industry in the previous year. The finalists for 2026, in alphabetical order, are: Ian Mortimer, President & Chief Executive Officer, Xenon Ph
Technologies, Biotechnologies, Services bancaires d’investissement, Santé
2026-05-01 7:30 AM EDT | Bloom Burton & Co. Inc.
BYT Holdings Ltd. Anticipates Failure-to-File Cease Trade Order
Vancouver, British Columbia--(Newsfile Corp. - April 30, 2026) - BYT Holdings Ltd. (CSE: BYT) ("BYT" or the "Company") has made an unsuccessful application to the British Columbia Securities Commission ("BCSC"), the Company's principal securities regulator in Canada, to approve a temporary management cease trade order ("MCTO") under National Policy 12-203 - Management Cease Trade Orders ("NP 12-203"), which, if granted, would have prohibited trading in securities of the Company by its
Technologies, Biotechnologies, Construction / bâtiments, Machinerie
2026-04-30 5:34 PM EDT | BYT Holdings Ltd.
Dr. Christina Rahm Recognized Nationally for Building Patent-Driven Manufacturing Behind The ROOT Brands Products
Franklin, Tennessee--(Newsfile Corp. - April 30, 2026) - Dr. Christina Rahm, scientist, inventor, and Founder and Chief Science Officer of The ROOT Brands, has received a Gold Stevie® Award in the 2026 American Business Awards® for Building and Scaling Patent-Driven Manufacturing Infrastructure (M
Biotechnologies, Aliments / boissons, Santé
2026-04-30 4:45 PM EDT | DRC Ventures
BioHarvest Sciences to Report First Quarter 2026 Financial Results on May 14, 2026
British Columbia and Rehovot, Israel--(Newsfile Corp. - April 30, 2026) - BioHarvest Sciences Inc. (NASDAQ: BHST) (FSE: 8MV0) ("BioHarvest" or the "Company"), a company pioneering its proprietary Botanical Synthesis™ platform, today announced that it will report its first quarter 2026 financial results before the market opening on Thursday, May 14, 2026. The Company will also host a conference call and webcast at 8:00 a.m. U.S. Eastern Time to discuss the results and provide
Biotechnologies, Pharmaceutique, Santé
2026-04-30 4:05 PM EDT | BioHarvest Sciences Inc.
Restart Life Advances Holy Crap Growth Strategy with New Protein SKU Nearing Commercialization
Vancouver, British Columbia--(Newsfile Corp. - April 30, 2026) - Restart Life Sciences Corp. (CSE: HEAL) (FSE: HN30) (OTC Pink: NMLSF) ("Restart Life" or the "Company") is pleased to provide an update on its collaboration with the University of Manitoba's Richardson Centre for Food Technology and Research (RCFTR), announcing the development of a new protein-focused SKU under its Holy Crap™ brand. This initiative extends the Company's existing research collaboration with RCFTR and
Technologies, Biotechnologies, Santé
2026-04-30 8:00 AM EDT | Restart Life Sciences Corp.
OS Therapies Announces EMA Initiates Rolling Review of Conditional Marketing Authorization Application for OST-HER2 in the Prevention or Delay of Recurrence in Fully Resected Pulmonary Metastatic Osteosarcoma
Conference call scheduled for Thursday, April 30, 2026, at 8:30 am ET to review new OST-HER2 immune pharmacodynamic biomarker response (seroconversion) data and review regulatory successes validating the OST-HER2 approach. Participants will include strategic advisors Dr. Craig Eagle and Dr. Bob Langer, and Osteosarcoma key opinion leader Dr. Peter Anderson from Cleveland Clinic. EMA and Australia TGA (ATGA) align on 3-year overall survival a
2026-04-30 6:00 AM EDT | OS Therapies
MustGrow Announces 2025 Financial Results
Investor Webcast: Thursday, April 30th at 4:00pm ET / 1:00pm PT Register/View Here: https://us02web.zoom.us/webinar/register/3117774401744/WN_eXcymymWSnicArxMPOiZVA Please join/register at least 5 minutes prior to the call. Questions emailed to info@mustgrow.ca will be addressed during the Q&A portion of the webcast. Saskatoon, Sa
Agriculture, Biotechnologies, Cannabis, Sélectionneurs de cannabis
2026-04-29 5:00 PM EDT | MustGrow Biologics Corp.
TempraMed Announces Continuance into Ontario
Vancouver, British Columbia--(Newsfile Corp. - April 29, 2026) - TempraMed Technologies Ltd. (CSE: VIVI) (FSE: 9DY) ("TempraMed" or the "Company"), a medical-technology innovator transforming how temperature-sensitive medications are stored and managed, is pleased to announce that it has continued out of the provincial jurisdiction of British Columbia under the Business Corporations Act (British Columbia) into the provincial jurisdiction of Ontario under the
Technologies, Biotechnologies, Pharmaceutique, Santé
2026-04-29 4:30 PM EDT | TempraMed Technologies Ltd.
Bachem Annual General Meeting 2026
Bubendorf, Switzerland--(Newsfile Corp. - April 29, 2026) - Bachem Holding AG (SIX: BANB) (“Bachem”) announced today that its Annual General Meeting 2026 has approved all proposals of the Board of Directors. A total of 78,3% of the 74‘977‘940 eligible shares were present. The Annual General Meetin
Biotechnologies, Produits chimiques, Soins de santé et hôpitaux, Pharmaceutique
2026-04-29 12:09 PM EDT | Bachem Holding AG
BioHarvest Sciences Announces Strategic Leadership Transition with Dr. Zaki Rakib Assuming Role of Chief Executive Officer to Accelerate "Two-Lens" Growth Strategy
British Columbia and Rehovot, Israel--(Newsfile Corp. - April 29, 2026) - BioHarvest Sciences Inc. (NASDAQ: BHST) (FSE: 8MV0) ("BioHarvest" or the "Company"), a leader in Botanical Synthesis™ technology, today announced a s
Biotechnologies, Pharmaceutique, Santé
2026-04-29 8:30 AM EDT | BioHarvest Sciences Inc.
Izotropic Africa Launches Operations in Casablanca
British Columbia and Casablanca, Morocco--(Newsfile Corp. - April 29, 2026) - Izotropic Corporation (CSE: IZO) (OTCQB: IZOZF) (FSE: 1R3) ("Izotropic", or the "Company"), a medical device company commercializing IzoView, a dedicated breast CT imaging system for the more accurate screening and diagnosis of breast cancers, announces the official launch of Izotropic Africa in Casablanca, Morocco, and th
2026-04-29 8:00 AM EDT | Izotropic Corporation